Dan Lu^1*, Jin Yan Jin^1*, Leonid Gibiansky^2*, William R. Gillespie^3*, Priya Agarwal^1*, Cheryl Jones^1*, Yu-Waye Chu^1*, Michael K. Wenger¹, Jamie Hirata¹, Chunze Li^1* and Sandhya Girish^1*

¹Genentech, Inc., South San Francisco, CA
²QuantPharm LLC, North Potomac, MD
³Metrum Research Group LLC, Tariffville, CT

Paul G. Rubinstein, MD¹, Page Moore, Ph.D^2*, David H. Henry, MD³, Lee Ratner, MD, PhD^4*, Elad Sharon, MD, MPH^5* and Ariela Noy, MD⁶

¹Department of Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL
²Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR
³Pennsylvania Onc./Hem. Associates, Philadelphia, PA
⁴Division of Oncology, Washington University School of Medicine, Saint Louis, MO
⁵National Cancer Institute, Bethesda, MD
⁶Medicine; Lymphoma Service, Memorial Sloan-Kettering Cancer Ctr., New York, NY

Wyndham H. Wilson, MD, PhD¹, Leslie L. Popplewell, MD², Tycel Phillips, MD^3*, Amy S. Kimball, MD, PhD⁴, Saurabh Chhabra, MD^5*, Jerry Ping, PhD^6*, Jutta Neuenburg, MD^6*, Nora Cavazos, MD^6*, Louis M Staudt, MD¹ and Sven de Vos, MD, PhD⁷

¹National Cancer Institute, Bethesda, MD
²City of Hope National Medical Center, Duarte, CA
³University of Michigan, Ann Arbor, MI
⁴University of Maryland School of Medicine, Baltimore, MD
⁵Medical University of South Carolina, Charleston, SC
⁶Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA
⁷Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA

Wojciech Jurczak, MD, PhD¹, Pier Luigi Zinzani, MD, PhD², Gianluca Gaidano, MD, PhD³, Andre Goy, MD⁴, Mariano Provencio, MD, PhD^5*, Zsolt Nagy, MD, PhD^6*, Tadeusz Robak, MD, PhD⁷, Kami J. Maddocks, MD⁸, Christian Buske, MD^9*, Roman Pawel Korolkiewicz, MD, PhD^10*, Frank Striebel, PhD^10* and Kristie Blum, MD¹¹

¹Jagiellonian University, Kraków, Poland
²Institute of Hematology “L. & A. Seràgnoli”, University of Bologna, Bologna, Italy
³Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
⁴John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
⁵Department of Medical Oncology, University Hospital Puerta De Hierro, Madrid, Spain
⁶1st Department of Internal Medicine, Semmelweis University, Budapest, Hungary
⁷Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Poland
⁸Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
⁹Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital of Ulm, Ulm, Germany
¹⁰MorphoSys AG, Martinsried, Germany
¹¹Department of Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH

Maria Christina Cox, MD PhD¹, Simone Battella^2*, Raffaella La Scaleia^2*, Arianna di Napoli^3*, Sabrina Pelliccia^1*, Alessandra Porzia^4*, Fabrizio Mainiero^2*, Bruno Monarca^3*, Luigi Ruco^3*, Angela Santoni^4,5* and Gabriella Palmieri^2*

¹Hematology, Azienda Ospedaliera S. Andrea, Rome, Italy
²Department of Experimental Medicine, Sapienza University, Rome, Italy
³Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy
⁴Department of Molecular Medicine, Sapienza University, Rome, Italy
⁵Istituto Pasteur-Fondazione Cenci Bolognetti, Rome, Italy

Lode J. Swinnen, MBChB¹, Anne O'Neill^2*, Philip H Imus, MD^1*, Sachin Gujar, MBBS, MD^3*, David Schiff, MD^4*, Lawrence Kleinberg^5*, Ranjana Advani⁶, Erin Dunbar, MD^7*, Dennis F. Moore Jr., MD⁸ and Stuart Grossman, MD^1*

¹Medical Oncology, Johns Hopkins, Baltimore, MD
²BIostatistics Core, Dana Farber / Harvard Cancer Center, Cambridge, MA
³Department of Radiology, Johns Hopkins, Baltimore, MD
⁴University of Virginia, Charlottesville, VA
⁵Radiation Oncology, Johns Hopkins, Baltimore, MD
⁶Stanford Cancer Center, Stanford, CA
⁷University of Florida, Gainesville, FL
⁸Cancer Center of Kansas, Wichita CCOP, Wichita, KS

Marina Motta, MD¹, Marco Chiarini, MSC^2*, Marta Petullà, PharmD^3*, Claudia Ghidini, BSC^2*, Marion Vaglio Tessitore, BSC^2*, Viviana Giustini, MSC^2*, Chiara Pagani, MD^3*, Antonella Anastasia, MD^3*, Samantha Ferrari, MD^3*, Alessandra Tucci^3*, Luisa Imberti, MD^2* and Giuseppe Rossi, MD⁴

¹Department of Haematology, AO Spedali Civili, Brescia, Italy
²Centro di Ricerca Emato-oncologica AIL, AO Spedali Civili, Brescia, Italy
³UO Ematologia, AO Spedali Civili, Brescia, Italy
⁴UO Ematologia, Azienda Ospedaliera Spedali Civili, Brescia, Italy

Bruce D. Cheson, MD¹, Peter C Trask, PhD, MPH^2*, John Gribben, MD, DSc³, Natalie Dimier^4*, Eva Kimby, MD, PhD⁵, Pieternella J Lugtenburg, MD, PhD⁶, Catherine Thieblemont⁷, Elisabeth Wassner Fritsch, MD^8* and Laurie H Sehn, MD, MPH⁹

¹Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC
²Genentech, Inc., South San Francisco, CA
³Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
⁴F. Hoffmann-La Roche Ltd, Welwyn, United Kingdom
⁵Department of Medicine at Huddinge, Division of Hematology, Karolinska Institutet, Stockholm, Sweden
⁶Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
⁷Hôpital Saint-Louis, Paris, France
⁸F. Hoffmann-La Roche Ltd, Basel, Switzerland
⁹British Columbia Cancer Agency and the University of British Columbia, Vancouver, BC, Canada

Veronika Bachanova, MD¹, Frederick Lansigan, MD², Donald P. Quick, MD³, Daniel Vlock, MD^4*, Stephen Gillies, PhD^4* and Ryotaro Nakamura, MD⁵

¹University of Minnesota Medical Center, Minneapolis, MN
²Hematology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
³Joe Arrington Cancer Center, Lubbock, TX
⁴Alopexx Oncology, LLC, Concord, MA
⁵Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA

Gunilla Enblad, MD PhD^1,2*, Hannah Karlsson, PhD^1*, Kristina Wikstrom, PhD^3*, Magnus Essand, PhD^1*, Barbara Savoldo, MD, PhD^4*, Malcolm K. Brenner, MD, PhD⁵, Gianpietro Dotti, MD^5*, Helene Hallbook, MD PhD^6,7*, Martin Hoglund, MD, PhD^8,9, Hans Hagberg, MD, PhD^2,10* and Angelica Loskog, PhD^11*

¹Immunology, Genetics and pathology, Uppsala university, Uppsala, Sweden
²Oncology, Uppsala university hospital, Uppsala, Sweden
³VECURA, Karolinska University Hospital, Stockholm, Sweden
⁴Center for Cell and Gene Therapy, Baylor Collage of Medicine, Houston, TX
⁵Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX
⁶Medical Sciences, Uppsala university, Uppsala, Sweden
⁷Section of Hematology, Uppsala university hospital, Uppsala, Sweden
⁸Uppsala University, Department of Medical Sciences, Section of Hematology, Uppsala, Sweden
⁹Uppsala university Hospital, Section of Hematology, Uppsala, Sweden
¹⁰Immunology, Genetics and Pathology, Uppsala university, Uppsala, Sweden
¹¹Immunology, Genetics and Pathology, Uppsala University, Uppsale, Sweden

Sandra Lockmer, MD, PhD stud^1,2*, Björn E Wahlin, MD, PhD^1,2, Bjorn Ostenstad, MD, PhD^3*, Åsa Jeppson-Ahlberg^2*, Birgitta Sander, MD, PhD^2,4 and Eva Kimby, MD, PhD¹

¹Department of Medicine at Huddinge, Division of Hematology, Karolinska Institutet, Stockholm, Sweden
²Karolinska University Hospital, Stockholm, Sweden
³Oslo University Hospital, Oslo, Norway
⁴Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden

Michael P. Chu, MD¹, Joshua Brody, MD², Holbrook E Kohrt, MD, Ph.D.¹, Matthew J. Frank, MD, PhD¹, Michael Khodadoust, MD, PhD¹, Sunil Reddy, MD^3*, Ranjana H Advani, MD⁴, Neel K. Gupta, M.D.⁵, Ginna Laport, MD⁶, Lauren S Maeda, MD⁵, Everett Meyer, MD, PhD⁷, David B. Miklos, MD, PhD⁸, Robert S. Negrin, MD⁶, Andrew R. Rezvani, MD⁹, Wen-Kai Weng, MD, PhD⁶, Kevin Sheehan, PhD^10*, Malek Faham, MD, PhD¹¹, Debra K Czerwinski¹, Ami Okada, PhD^1* and Ronald Levy, MD⁵

¹Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
²Ichan School of Medicine at Mount Sinai, New York, NY
³Medicine/Oncology, Stanford University School of Medicine, Stanford, CA
⁴Stanford University Medical Center, Stanford, CA
⁵Stanford University, Stanford, CA
⁶Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA
⁷Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA
⁸Department of Medicine, Division of Blood and Marrow Transplantation, Stanford University Medical Center, Stanford, CA
⁹Division of Blood & Marrow Transplantation, Stanford University, Stanford, CA
¹⁰Stanford medical center, Stanford, CA
¹¹Sequenta, Inc., South San Francisco, CA

Steven M Horwitz, MD¹, Andrei R. Shustov, MD², Andres Forero-Torres³, Nancy L Bartlett, MD⁴, Ranjana Advani⁵, Barbara Pro⁶, Robert Chen⁷, Andrew J Davies, MRCP^8*, Tim Illidge⁹, Dirk Huebner¹⁰, Dana A. Kennedy¹¹ and Michelle A. Fanale¹²

¹Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
²University of Washington Medical Center – Seattle Cancer Care Alliance & Fred Hutchinson Cancer Research Center, Seattle, WA
³University of Alabama at Birmingham, Birmingham, AL
⁴Washington University School of Medicine, Saint Louis, MO
⁵Stanford Cancer Center, Stanford, CA
⁶Thomas Jefferson University, Philadelphia, PA
⁷City of Hope National Medical Center, Duarte, CA
⁸Southampton University, SCTU, Southampton, United Kingdom
⁹Institute of Cancer Sciences, University of Manchester, Manchester, United Kingdom
¹⁰Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceuticals Limited, Cambridge, MA
¹¹Seattle Genetics, Inc., Bothell, WA
¹²University of Texas MD Anderson Cancer Center, Houston, TX

Matthew A. Lunning, DO¹, Julie Vose¹, Nathan Fowler, MD², Loretta Nastoupil, MD³, Jan A. Burger, MD, PhD⁴, William Wierda, MD, PhD³, Marshall T. Schreeder, MD⁵, Tanya Siddiqi, MD⁶, Christopher Flowers, MD⁷, Jonathon B. Cohen, MD⁷, Susan Blumel, RN, BSN^1*, Myra Miguel, RN^3*, Kathy Cutter, RN, BSN^5*, Emily K. Pauli, BMBS, PharmD^5*, Ryan Handy, BS^7*, Peter Sportelli⁸, Hari P. Miskin, MS^8*, Michael S. Weiss^8* and Susan O'Brien, MD⁹

¹University of Nebraska Medical Center, Omaha, NE
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Clearview Cancer Institute, Huntsville, AL
⁶City of Hope National Medical Center, Duarte, CA
⁷Winship Cancer Institute of Emory University, Atlanta, GA
⁸TG Therapeutics, Inc., New York, NY
⁹University of California - Irvine, Orange, CA

Debra K Czerwinski¹, Steven R Long, MD^2*, Michael Khodadoust, MD, PhD¹, Matthew J. Frank, MD, PhD¹, Michael P. Chu, MD¹, Ami Okada, PhD^1*, Kathleen A McDonald, BA^1*, Holbrook E Kohrt, MD, Ph.D.¹, Nancy L Bartlett, MD³, Patrick M. Reagan, MD⁴, Jonathan W. Friedberg, MD, MMSc⁵, Leo I. Gordon, MD⁶, Robert Coffman, PhD⁷, Robert Janssen, MD^7* and Ronald Levy, MD¹

¹Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
²Pathology, Stanford University School of Medicine, Stanford, CA
³Washington University School of Medicine, Saint Louis, MO
⁴Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
⁵University of Rochester, Rochester, NY
⁶Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Chicago, IL
⁷Dynavax Technologies, Berkeley, CA

Sheeba K. Thomas, MD¹, Wael A. Harb, MD², Joseph Thaddeus Beck, MD³, Gabrail Nashat, MD^4*, M. Lia Palomba, MD⁵, Stephen M Ansell, MD, PhD⁶, Herbert Eradat, MD⁷, Edward N. Libby III, MD⁸, Ranjana H Advani, MD⁹, Julio Hajdenberg, MD^10*, Leonard T Heffner, MD¹¹, James Hoffman, MD^12*, David H. Vesole, MD¹³, Lindsey Simov^14*, Nancy Wyant^14*, Julie Brevard, MPH^14*, James O'Leary, MD^14* and Sudhir Agrawal, D.Phil^14*

¹Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Horizon Oncology Center, Lafayette, IN
³Highlands Oncology Group, P.A., Fayetteville, AR
⁴Gabrail Cancer Center, Canton, OH
⁵Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Department of Medicine/Division of Hematology, Mayo Clinic, Rochester, MN
⁷David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA
⁸Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA
⁹Stanford University Medical Center, Stanford, CA
¹⁰M.D. Anderson Orlando, Orlando, FL
¹¹Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
¹²Division of Hematology-Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
¹³John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
¹⁴Idera Pharmaceuticals, Cambridge, MA

Antonello Pinto, MD^1*, Vincenzo Pavone, MD², Francesco Angrilli, MD^3*, Mariangela Saggese, PharmD^1*, Stefania Crisci, ScD^1*, Caterina Patti, MD^4*, Pier Luigi Zinzani, MD, PhD⁵, Alfonso Maria D'Arco, MD^6*, Elena Cavalieri, MD^7*, Attilio Guarini, MD^8*, Michele Spina, MD⁹, Daniela Carlino, MD^2*, Simona Falorio, MD^3*, Emanuela Morelli, MD^1*, Manuela Arcamone, MD^1*, Ferdinando Frigeri, MD, PhD^1*, Annarosaria De Chiara, MD^10*, Rosaria De Filippi, MD, PhD^11* and Gaetano Corazzelli, MD^1*

¹Hematology-Oncology and Stem Cell Transplantation Unit, Istituto Nazionale Tumori, Fondazione 'G. Pascale', IRCCS, Naples, Italy
²Division of Hematology, Ospedale G. Panico, Tricase, Lecce, Italy
³Hematology and BMT Center, Spirito Santo Hospital, Pescara, Italy
⁴Dept. of Hematology, Ospedale V. Cervello, Palermo, Italy
⁵Institute of Hematology “L. & A. Seràgnoli”, University of Bologna, Bologna, Italy
⁶Hematology-Oncology, Ospedale A. Tortora, Pagani, Italy
⁷Hematology, Azienda Ospedaliera Sant'Andrea, Rome, Italy
⁸Hematology, Ospedale oncologico 'Giovanni Paolo II', I.R.C.C.S., Bari, Italy
⁹Division of Medical Oncology, National Cancer Institute, Aviano, Italy
¹⁰Pathology Unit, Istituto Nazionale Tumori Fondazione 'G. Pascale', Naples, Italy
¹¹Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy

Georg Hess, MD^1*, Simon Rule, MD^2*, Wojciech Jurczak, MD, PhD³, Mats Jerkeman, MD, PhD⁴, Rodrigo Santucci, MD⁵, Chiara Rusconi, MD^6*, Dolores Caballero^7*, Cristina M. Joao, MD, PhD^8*, Mathias Witzens-Harig, MD^9*, Isabelle Bence-Bruckler, MD, FRCPC^10*, Seok-Goo Cho^11*, Nibedita Bandyopadhyay, PhD^12*, Jenna Goldberg, MD^12*, John Bothos, PhD^12*, Christopher Enny, BS^12*, Jessica Vermeulen, MD, PhD^13*, Shana Traina, PhD^14* and Martin H. Dreyling, MD, PhD¹⁵

¹Department of Internal Medicine III (Hematology, Oncology, Pneumology), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
²Department of Haematology, Derriford Hospital, Plymouth, United Kingdom
³Jagiellonian University, Kraków, Poland
⁴Department of Oncology, Skåne University Hospital, Lund University, Lund, Sweden
⁵HEMOMED, São Paulo, Brazil
⁶Division of Hematology, Niguarda Ca' Granda Hospital, Milan, Italy
⁷Hematologia, Hospital Clinico Universitario Salamanca, Salamanca, Spain
⁸Hematology department, Instituto Português de Oncologia de Lisboa, Lisbon, Portugal
⁹Dep. Med. V, University Hospital Heidelberg, Heidelberg, Germany
¹⁰Division of Hematology, The Ottawa Hospital, Ottawa, ON, Canada
¹¹Department of Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea
¹²Janssen Research & Development, Raritan, NJ
¹³Janssen Pharmaceutical Research & Development, Leiden, Netherlands
¹⁴Janssen Pharmaceutical Research & Development, Raritan, NJ
¹⁵Dept. of Medicine III, Univ. Hospital Grosshadern/LMU, Munich, Germany

Peter Martin, MD¹, Armando Armas, MD^2*, Ajay K Gopal, MD³, Emmanuel Gyan, MD, PhD⁴, Nina D. Wagner-Johnston, MD⁵, Jan Walewski, MD PhD Prof⁶, Steve Abella, MD^7*, Wei Ye^7*, Betsy Philip^7*, Bess Sorenson^7* and Sven de Vos, MD, PhD⁸

¹Division of Hematology/Oncology, Weill Cornell Medical College, New York, NY
²Calaway Young Cancer Center, Glenwood Springs, CO
³Division of Medical Oncology, University of Washington, Seattle, WA
⁴Service d'Hématologie et thérapie cellulaire, Centre Hospitalier Universitaire, Tours, France
⁵Department of Medicine, Washington University School of Medicine, St Louis, MO
⁶Department of Lymphoproliferative Diseases, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
⁷Gilead Sciences, Inc., Foster City, CA
⁸Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA

Herve Ghesquieres, MD, PhD^1*, Celine Segura-Ferlay, MS^2*, Gaelle Fossard, MD^1*, Francois Ducray, MD, PhD^3*, Violaine Safar, MD^1*, Philippe Rey, MD^1*, Emmanuelle Nicolas-Virelizier, MD^1*, Catherine Sebban, MD^1*, Amine Belhabri, MD^1*, Pierre Biron, MD^1*, Emmanuel Jouanneau, MD, PhD^3*, David Meyronnet, MD, PhD^4*, Catherine Chassagne-Clement, MD^5*, Jerome Honnorat, MD, PhD^3* and Jean-Yves Blay, MD, PhD¹

¹Onco-hematology, Centre Leon Berard, University Claude Bernard Lyon 1, Lyon, France
²Statistics, Centre Leon Berard, University Claude Bernard Lyon 1, Lyon, France
³Neurology, Hopital Neurologique, University Claude Bernard Lyon 1, Lyon, France
⁴Pathology, Hopital Neurologique, University Claude Bernard Lyon 1, Lyon, France
⁵Pathology, Centre Leon Berard, University Claude Bernard Lyon 1, Lyon, France

Jeff P. Sharman, MD¹, Leonard M. Klein, MD², Michael Boxer, MD³, Kathryn S. Kolibaba, MD⁴, Steve Abella, MD^5*, Clarence Eng, MPH^5*, Jing He^6*, Jing Hu, PhD^5* and Christopher A. Yasenchak, MD⁷

¹Willamette Valley Cancer Institute, Springfield, OR
²Illinois Cancer Specialists, Niles, IL
³Arizona Oncology Associates, Tucson, AZ
⁴Compass Oncology/US Oncology Research, Vancouver, WA
⁵Gilead Sciences, Inc., Foster City, CA
⁶Gilead Sciences, Inc, Foster City, CA
⁷Willamette Valley Cancer Institute and Research Center/US Oncology Research, Springfield, OR

Christa Roe, RN, BS, OCN^1*, Jennifer Rock-Klotz, BA^1*, Elyce Turba, RN, MSN, OCN^1*, Christopher Rodriguez Salamanca, PA^1*, Janice Bennett, MS, ARNP-C^1*, Farrah Farquharson, PA^1*, Sem Bastien, MS, ARNP-C^1*, Barbara Williams, RN, BS, OCN^2*, Rebecca Levy, MS, ARNP-C^2*, Yibo Li, BS^1*, Michael Montejo, M.D.^3*, Ernesto Ayala, M.D.⁴, Pedro Horna, M.D.^5*, Lewis F Glass, M.D.^2*, Rami S. Komrokji, MD⁶ and Lubomir Sokol, M.D, Ph.D.¹

¹Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²Cutaneous Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
³Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁴Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL
⁵Hematopathology and Laboratory Medicine, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁶Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Andrés J.M. Ferreri¹, Marianna Sassone^1*, Marianna Chiozzotto^2*, Michele Spina, MD³, Alessandra Tucci^4*, Alice Di Rocco^5*, Alberto Fabbri^6*, Caterina Stelitano^7*, Maurizio Frezzato^8*, Renato Zambello^9*, Giovanni Bertoldero^10*, Chiara Rusconi, MD^11*, Annalisa Arcari^12*, Lydia Scarfo^1*, Silvia Govi^1*, Maurilio Ponzoni, M.D.^1,13 and Francesco Zaja, MD²

¹Unit of Lymphoid Malignancies, Department of Onco-Hematology, San Raffaele Scientific Institute, Milan, Italy
²Centro Trapianti e Terapie Cellulari “Carlo Melzi” DISM, Azienda Ospedaliera Universitaria S. Maria Misericordia, Udine, Italy
³Division of Medical Oncology, National Cancer Institute, Aviano, Italy
⁴Division of Hematology, Spedali Civili, Brescia, Italy
⁵Division of Hematology, University "La Sapienza", Rome, Italy
⁶A.O. Università Senese, Siena, Italy
⁷Divsion of Hematology, A. O. Bianchi-Melacrino-Morelli, Reggio Calabria, Italy
⁸Division of Hematology, San Bortolo Hospital, Vicenza, Italy
⁹Department of Medicine, Hematology and Clinical Immunology Section, Padua University School of Medicine, Padua, Italy
¹⁰U.O. di Oncologia ed Ematologia Oncologica, Ospedale di Mirano, Mirano, Italy
¹¹Division of Hematology, Niguarda Ca' Granda Hospital, Milan, Italy
¹²Department of Oncology and Hematology, G. da Saliceto Hospital, Piacenza, Italy
¹³Pathology Unit, San Raffaele Scientific Institute, Milan, Italy